Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model
- 20 April 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 6 (8) , 1393-1399
Abstract
In our efforts to develop hybrid compounds of curcumin and melatonin as potential disease-modifying agents for Alzheimer’s disease (AD), a potent lead hybrid compound, Z-CM-I-1, has been recently identified and biologically characterized in vitro. In this work, we report the in vivo effects of Z-CM-I-1 on AD pathologies in an APP/PS1 transgenic AD model. Our studies demonstrated that Z-CM-I-1 significantly decreased the accumulation of Aβ in the hippocampus and cortex regions of the brain and reduced inflammatory responses and oxidative stress after treatment for 12 weeks at 50 mg/kg per dose via oral administration. Furthermore, Z-CM-I-1 significantly improved synaptic dysfunction evidenced by the increased expression of synaptic marker proteins, PSD95 and synaptophysin, indicating its protective effects on synaptic degeneration. Lastly, we demonstrated that Z-CM-I-1 significantly increased the expression level of complexes I, II, and IV of the mitochondria electron transport chain in the brain tissue of APP/PS1 mice. Collectively, these results clearly suggest that Z-CM-I-1 is orally available and exhibits multifunctional properties in vivo on AD pathologies, thus strongly encouraging further development of this lead compound as a potential disease-modifying agent for AD patients.Keywords
Funding Information
- Virginia and Buddy Spitz
- National Institute on Aging (R01AG041161)
- Commonwealth of Virginia
This publication has 49 references indexed in Scilit:
- Inflammatory Proteins in Plasma and the Risk of DementiaArchives of Neurology, 2004
- Increased Morphological Diversity of Microglia in the Activated Hypothalamic Supraoptic NucleusJournal of Neuroscience, 2003
- Role of mitochondrial dysfunction in Alzheimer's diseaseJournal of Neuroscience Research, 2002
- Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain existsJournal of Alzheimer’s Disease, 2002
- Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s diseaseFree Radical Biology and Medicine, 2002
- Co-expression of multiple transgenes in mouse CNS: a comparison of strategiesBiomolecular Engineering, 2001
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on DementiaEuropean Archives of Psychiatry and Clinical Neuroscience, 1996
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severityAnnals of Neurology, 1990